Ding Kai
From Bioblast
Revision as of 03:42, 1 March 2020 by Gnaiger Erich (talk | contribs) (Gnaiger Erich moved page Ding K to Ding Kai over redirect)
| Name | Ding Kai, |
|---|---|
| Institution | Department of Pharmaceutical Sciences/BRITE
North Carolina Central University |
| Address | 302 E. Lawson Street
BRITE Building, Room 2025, 27707 |
| City | Durham |
| State/Province | North Carolina (NC) |
| Country | USA |
| Weblink | |
| O2k-Network Lab | US NC Durham Li PA |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Lu 2018 ACS Infect Dis | 2018 | Lu X, Williams Z, Hards K, Tang J, Cheung CY, Aung HL, Wang B, Liu Z, Hu X, Lenaerts AJ, Woolhiser L, Hastings C, Zhang X, Wang Z, Rhee KY, Ding K, Zhang T, Cook GM (2018) A pyrazolo[1,5-a]pyridine inhibitor of the respiratory cytochrome bcc complex for the treatment of drug-resistant tuberculosis. ACS Infect Dis 5:239-49. |
